Literature DB >> 8697416

Detection of aneuploidy in interphase nuclei from non-small cell lung carcinomas by fluorescence in situ hybridization using chromosome-specific repetitive DNA probes.

T Taguchi1, J Y Zhou, M Feder, S Litwin, A J Klein-Szanto, J R Testa.   

Abstract

Interphase fluorescence in situ hybridization (FISH) is particularly useful for detecting chromosome changes in tumors exhibiting a low mitotic index, as is the case in many human non-small cell lung carcinomas (NSCLCs). A panel of centromeric DNA probes specific for the autosomes 6, 7, 8, 9, 12, 17, and 18 was used to analyze 17 primary NSCLCs. Evidence for aneuploidy was obtained in all specimens. Gain of part or all of chromosome 7 was especially prominent, occurring in a large population of cells in each of 14 tumors (82%). Extra centromeric copies of chromosomes 6, 12, and 17 were also common, being observed in 9 to 11 cases each. Gain of chromosome 9 was infrequent (three tumors). In two cases, most of the nuclei had only a single chromosome 9 fluorescent signal. Karyotypic findings were available for six cases and were generally consistent with the FISH data. Both methods revealed considerable heterogeneity within individual tumors. NSCLC specimens from 26 males were assayed with a Y-specific centromeric sequence; loss of the Y was observed in 13 cases (50%). These investigations demonstrate the feasibility of interphase FISH for the successful analysis of numerical chromosome changes in NSCLCs.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8697416     DOI: 10.1016/0165-4608(95)00355-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization.

Authors:  Maura Santos Romeo; Irina A Sokolova; Larry E Morrison; Chan Zeng; Anna E Barón; Fred R Hirsch; York E Miller; Wilbur A Franklin; Marileila Varella-Garcia
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

2.  Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm.

Authors:  Maosong Ye; Xiaoxuan Zheng; Xin Ye; Juncheng Zhang; Chuoji Huang; Zilong Liu; Meng Huang; Xianjun Fan; Yanci Chen; Botao Xiao; Jiayuan Sun; Chunxue Bai
Journal:  Front Oncol       Date:  2021-03-11       Impact factor: 6.244

3.  Chromosomal aneusomy in bronchial high-grade lesions is associated with invasive lung cancer.

Authors:  Steinn Jonsson; Marileila Varella-Garcia; York E Miller; Holly J Wolf; Tim Byers; Sarah Braudrick; Porntip Kiatsimkul; Marina Lewis; Timothy C Kennedy; Robert L Keith; Johannes Bjornsson; Annette McWilliams; Stephen Lam; Fred R Hirsch; Wilbur A Franklin
Journal:  Am J Respir Crit Care Med       Date:  2007-11-07       Impact factor: 21.405

4.  The relationship between the presence of chromosomal instability and prognosis of squamous cell carcinoma of the lung: fluorescence in situ hybridization analysis of paraffin-embedded tissue from 47 Korean patients.

Authors:  Jung-Wan Yoo; Kwang Won Seo; Se Jin Jang; Yeon-Mock Oh; Tae Sun Shim; Woo Sung Kim; Dong-Soon Lee; Sang-Do Lee; Chang-Min Choi
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

5.  Detection of circulating genetically abnormal cells using 4-color fluorescence in situ hybridization for the early detection of lung cancer.

Authors:  Mingxiang Feng; Xin Ye; Baishen Chen; Juncheng Zhang; Chuoji Huang; Chunxue Bai; Miao Lin; Haining Zhou; Meng Huang; Yanci Chen; Yunhe Zhu; Botao Xiao; Ruth L Katz
Journal:  J Cancer Res Clin Oncol       Date:  2021-02-06       Impact factor: 4.553

6.  Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.

Authors:  Alexander C Mackinnon; Maria Tretiakova; Les Henderson; Rajendra G Mehta; Benjamin C Yan; Loren Joseph; Thomas Krausz; Aliya N Husain; Mary E Reid; Ravi Salgia
Journal:  J Clin Pathol       Date:  2010-11-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.